Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

NCT02032784 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.

NCT NCT02032784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02032784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
Lead sponsor
AdventHealth
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 2014
Completion date
July 6, 2020
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma